Skip to main content
. 2016 Jul 19;18:159. doi: 10.1186/s13075-016-1052-8

Fig. 1.

Fig. 1

Disease activity based on CDAI at baseline and 6 months of biologic therapy.  CDAI clinical disease activity index, LOCF last observation carried forward, IFX infliximab, TCZ tocilizumab, ABT abatacept